当前位置:首页 - 行情中心 - 博士眼镜(300622) - 财务分析 - 利润表

博士眼镜

(300622)

  

流通市值:52.88亿  总市值:77.86亿
流通股本:1.55亿   总股本:2.28亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入326,159,936.891,202,816,100.75915,266,819.34600,948,185.65
营业收入326,159,936.891,202,816,100.75915,266,819.34600,948,185.65
二、营业总成本288,262,481.441,071,983,530.11822,195,164.51540,825,871.28
营业成本136,723,780.67460,535,852.38379,378,092.84251,842,867.87
税金及附加1,612,556.64,148,210.682,917,528.062,069,074.86
销售费用125,116,862.95500,844,535.05366,192,851.04239,191,021.3
管理费用22,542,816.9495,455,655.4164,089,711.1441,834,399.89
研发费用531,316.893,079,829.312,470,802.021,879,756.73
财务费用1,735,147.397,919,447.287,146,179.414,008,750.63
其中:利息费用2,170,050.748,326,007.426,841,928.014,204,821.17
其中:利息收入1,357,328.255,682,722.974,250,598.142,543,115.98
加:公允价值变动收益1,451,900.12,208,700.82,073,214.471,836,330.9
加:投资收益1,660,386.1310,615,965.837,677,443.14,955,210.81
资产处置收益-34,393.362,348,494.021,430,163.55365,012.94
资产减值损失(新)-1,401,051.32-21,225,825.24-3,163,640.34-2,434,492.35
信用减值损失(新)-1,069,851.41-729,367.43-68,837.84-929,060.07
其他收益743,822.626,020,931.242,838,042.241,897,461.51
营业利润平衡项目0000
四、营业利润39,248,268.21130,071,469.86103,858,040.0165,812,778.11
加:营业外收入27,236.83472,739.99233,719.299,034.68
减:营业外支出134,366.131,428,269.991,218,519.54910,269.92
利润总额平衡项目0000
五、利润总额39,141,138.91129,115,939.86102,873,239.6765,001,542.87
减:所得税费用8,017,251.1227,798,567.8620,074,005.7312,942,644.05
六、净利润31,123,887.79101,317,37282,799,233.9452,058,898.82
持续经营净利润31,123,887.79101,317,37282,799,233.9452,058,898.82
归属于母公司股东的净利润30,177,843.86103,628,433.5783,484,416.4152,384,653.93
少数股东损益946,043.93-2,311,061.57-685,182.47-325,755.11
(一)基本每股收益0.170.590.480.3
(二)稀释每股收益0.170.590.480.3
八、其他综合收益-235,515.011,539,030.05-228,217.17479,708.58
归属于母公司股东的其他综合收益-235,515.011,539,030.05-228,217.17479,708.58
九、综合收益总额30,888,372.78102,856,402.0582,571,016.7752,538,607.4
归属于母公司股东的综合收益总额29,942,328.85105,167,463.6283,256,199.2452,864,362.51
归属于少数股东的综合收益总额946,043.93-2,311,061.57-685,182.47-325,755.11
公告日期2025-04-292025-04-152024-10-302024-08-29
审计意见(境内)标准无保留意见
TOP↑